Smith & Nephew’s First Plant In China Commences Operation
This article was originally published in PharmAsia News
Executive Summary
Smith & Nephew has officially started operating its first Chinese production base in Suzhou industrial park, the latest to join the some 50 international medical corporations congregated here. The plant's registered capital of $20 million will bring the total investment of Smith & Nephew Medical (Suzhou) to $60 million. The factory occupies 12,800 square meters of the 40,000-square-meter site and will produce mainly the wound care product Allevyn Thin Dressing. (Click here for more - Chinese Language)